⌘K

Home/Filings/4/0001683168-23-008429

4//SEC Filing

Abecassis Michael M 4

Accession 0001683168-23-008429

CIK 0001157075other

View on SEC.gov Company Profile

Filed

Nov 21, 7:00 PM ET

Accepted

Nov 22, 5:00 PM ET

Size

5.3 KB

Accession

0001683168-23-008429

Insider Transaction Report

Form 4

Period: 2023-11-20

PharmaCyte Biotech, Inc.PMCB

Abecassis Michael M

Director

Transactions

Award
Stock Option (Right to Buy)
2023-11-20+61,248→ 61,248 total
Exercise: $2.18From: 2023-11-20Exp: 2033-11-20→ Common Stock (61,248 underlying)

Documents

1 file

4
ownership.xmlPrimary

Issuer

PharmaCyte Biotech, Inc.

CIK 0001157075

Entity typeother

Related Parties

1

filerCIK 0001879281

Filing Metadata

Form type: 4
Filed: Nov 21, 7:00 PM ET
Accepted: Nov 22, 5:00 PM ET
Size: 5.3 KB

View on SEC.gov